Management of Global T Wave Inversion with Elevated Troponin I in Acute Gastroenteritis

Initial Assessment and Workup

The European Society of Cardiology recommends obtaining a 12-lead ECG immediately to assess for ischemic changes, conduction abnormalities, and ST-segment changes in patients with global T wave inversion and elevated troponin I in the setting of acute gastroenteritis 1, 3
Measure cardiac-specific troponin I at presentation and repeat 6-12 hours later to identify rising/falling patterns indicative of acute myocardial injury, as suggested by the European Heart Journal 1, 2
Perform echocardiography to assess for structural heart disease, wall motion abnormalities, and ventricular function, as recommended by the European Heart Journal 3, 5
Evaluate for other cardiac biomarkers including BNP/NT-proBNP to assess for heart failure, according to the Journal of Clinical Oncology 6, 5

Type 1 myocardial infarction (acute coronary syndrome) should be considered in the differential diagnosis, as stated by the European Heart Journal 1, 3
Type 2 myocardial infarction due to supply-demand mismatch from gastroenteritis (tachycardia, hypotension, dehydration) is a possible cause, according to the European Heart Journal 2
Non-cardiac causes of troponin elevation (e.g., pulmonary embolism, renal failure) should also be considered, as noted by the European Heart Journal and the Journal for ImmunoTherapy of Cancer 7, 5

High-risk features include persistent or recurrent chest pain, dynamic ST-segment or T-wave changes, markedly elevated troponin (>5 times upper limit of normal), and hemodynamic instability or arrhythmias, as identified by the European Heart Journal 3, 2
The European Heart Journal recommends that patients with these high-risk features undergo emergency coronary angiography and receive aggressive treatment, including aspirin, low-molecular-weight heparin, beta-blockers, and nitrates 3

For high-risk patients, the European Heart Journal suggests initiating baseline treatment, including aspirin, low-molecular-weight heparin, beta-blockers, and nitrates, and considering GPIIb/IIIa receptor inhibitor followed by coronary angiography during hospitalization 3
For low-risk patients, the European Heart Journal recommends providing supportive care for gastroenteritis, continuing cardiac monitoring and serial troponin measurements, and considering non-invasive cardiac testing (stress test) before discharge or in the following days 1, 3

Mild troponin elevations (e.g., <2–3 times the ULN) may not require workup for type 1 MI unless strongly suggested clinically by angina chest pain and/or significant ECG changes, as stated by the European Heart Journal 2

The European Heart Journal recommends repeat ECG and echocardiography before discharge or at follow-up to assess for resolution of abnormalities, and considering cardiology follow-up for patients with persistent ECG changes or elevated troponin 3
Aggressive management of cardiovascular risk factors is recommended for patients with confirmed coronary artery disease, according to the European Heart Journal 3